ANAVEX LIFE SCIENCES CORP. — Director's Dealing 2021

Jul 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK: 0001314052
Period of Report: 2021-06-29

Reporting Person: Boenisch Sandra (PFO and Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-29	Common Stock	M	25000	$5.68	Acquired	47963	Direct
2021-06-29	Common Stock	M	106696	$3.28	Acquired	154659	Direct
2021-06-29	Common Stock	M	35000	$5.92	Acquired	189659	Direct
2021-06-29	Common Stock	S	166696	$26.53	Disposed	22963	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-29	Stock Option (Right to Buy)	$5.68	M	25000	Disposed	2025-10-02	Common Stock (25000)	Direct
2021-06-29	Stock Option (Right to Buy)	$3.28	M	106696	Disposed	2026-09-22	Common Stock (106696)	Direct
2021-06-29	Stock Option (Right to Buy)	$5.92	M	35000	Disposed	2027-05-12	Common Stock (35000)	Direct

Footnotes

F1: The options subject to this grant vested quarterly over a three-year period commencing on December 31, 2015.

F2: The options subject to this grant vested quarterly over a three-year period commencing on June 30, 2017.